Danshen Modulates Nrf2-mediated Signaling Pathway in Cisplatin-induced Renal Injury
Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days befo...
Saved in:
Published in | Current medical science Vol. 37; no. 5; pp. 761 - 765 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Wuhan
Huazhong University of Science and Technology
01.10.2017
Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China School of Pharmaceutical Sciences, Central South University, Changsha 410013, China%Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China%Department of Nephrology, the Second Xiangya Hospital Central South University, Changsha 410011, China%Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes(GSH-Px and SOD) and peroxidative product(MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes(GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway. |
---|---|
AbstractList | Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes (GSH-Px and SOD) and peroxidative product (MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes (GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway. Summary Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes (GSH-Px and SOD) and peroxidative product (MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes (GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway. Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes (GSH-Px and SOD) and peroxidative product (MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes (GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway.Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes (GSH-Px and SOD) and peroxidative product (MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes (GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway. Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes(GSH-Px and SOD) and peroxidative product(MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes(GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway. |
Author | 曹思思;颜苗;侯振彦;陈莹;蒋云生;樊新荣;方平飞;张毕奎 |
AuthorAffiliation | Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha 410011, China;School of Pharmaceutical Sciences, Central South University, Changsha 410013, China;Department of Nephrology, the Second Xiangya Hospital, Central South University, Changsha 410011, China;Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China |
AuthorAffiliation_xml | – name: Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China;School of Pharmaceutical Sciences, Central South University, Changsha 410013, China%Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China%Department of Nephrology, the Second Xiangya Hospital Central South University, Changsha 410011, China%Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China |
Author_xml | – sequence: 1 fullname: 曹思思;颜苗;侯振彦;陈莹;蒋云生;樊新荣;方平飞;张毕奎 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29058292$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtv3CAURlGVqnm0P6CbyuqqUkTLBRvMspq-IqUPNdkjzMPD1IMnYCuZfx8iT1qpi6wA6Zx7L989RUdxjA6h10DeAyHiQwZoJMcEBIaWAIZn6ASkZBhYQ4_KnQuKiWDsGJ3mvCGkEZzWL9AxlaRpqaQn6OqTjnntYvV9tPOgJ5erH8lTvHU2lJetrkIf9RBiX_3S0_pW76sQq1XIuwKHiEO0synYb1eo6iJu5rR_iZ57PWT36nCeoesvn69X3_Dlz68Xq4-X2NRETFhwq1tRg-WG8lYI6jvPPDjiDHW11KIDTrVz4J0nDLxorSXMcmcMdFazM3S-lL3V0evYq804pzJFVtNm_8fe3XXK0ZINaQjIQr9b6F0ab2aXJ7UN2bhh0NGNc1Ygm7qmrOAFfXNA567koHYpbHXaq8fUCiAWwKQx5-S8MmEqcYxxSjoMCoh62I9a9qPKDOphPwqKCf-Zj8Wfcuji5MLG3qV_H31KentotB5jf1O8v524YJIzTiS7B0V_rVI |
CitedBy_id | crossref_primary_10_1253_circj_CJ_23_0864 crossref_primary_10_3389_fphar_2023_1153297 crossref_primary_10_3389_fphar_2020_619201 crossref_primary_10_1155_2022_9275056 crossref_primary_10_1007_s11255_020_02485_z crossref_primary_10_1007_s12011_021_02913_w crossref_primary_10_1186_s12906_021_03398_9 |
Cites_doi | 10.1371/journal.pone.0074318 10.1124/jpet.110.170084 10.1007/s11596-016-1540-8 10.1089/acm.2011.0041 10.1016/j.lfs.2004.02.034 10.1038/ki.2013.248 10.1038/ki.2015.328 10.1016/j.phymed.2015.03.003 10.1007/s00204-006-0173-2 10.1002/biof.1094 10.1016/S0254-6272(15)30102-3 10.1371/journal.pone.0101668 10.1016/j.etp.2008.09.003 10.3390/cancers8020021 10.1016/j.jep.2011.11.046 10.3390/ijms131013621 10.1016/S2221-1691(12)60112-9 10.1016/j.neulet.2013.02.069 10.1038/ki.2013.330 10.2215/CJN.08070715 10.1152/ajprenal.2000.278.5.F726 10.3390/toxins2112490 10.1016/j.intimp.2016.06.024 10.1016/j.jep.2013.11.025 10.1016/S0272-6386(86)80112-3 10.1038/ki.2009.157 10.1002/jbt.21833 |
ContentType | Journal Article |
Copyright | Huazhong University of Science and Technology and Springer-Verlag GmbH Germany 2017 Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Huazhong University of Science and Technology and Springer-Verlag GmbH Germany 2017 – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION NPM 7X8 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.1007/s11596-017-1801-1 |
DatabaseName | 中文科技期刊数据库 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Danshen Modulates Nrf2-mediated Signaling Pathway in Cisplatin-induced Renal Injury |
EISSN | 1993-1352 2523-899X |
EndPage | 765 |
ExternalDocumentID | tjykdxxb_e201705019 29058292 10_1007_s11596_017_1801_1 673963609 |
Genre | Journal Article |
GrantInformation_xml | – fundername: grants from the National Natural Science Foundation of China funderid: (.81202985 and 81573686) |
GroupedDBID | -5E -5G -BR -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 29K 29~ 2B. 2C~ 2J2 2KG 2KM 2LR 2RA 2~H 30V 4.4 408 40D 40E 53G 5GY 5VS 6NX 8TC 8UJ 92F 92I 92L 95- 95. 95~ 96X AAAVM AABHQ AAJKR AANXM AARHV AARTL AAYIU AAYQN AAYTO ABFTV ABJNI ABJOX ABKCH ABMNI ABNWP ABQBU ABTMW ACGFS ACHXU ACKNC ACOMO ACSNA ACUDM ADHIR ADINQ ADKPE ADURQ ADYFF ADZKW AEBTG AEGNC AEJHL AEKMD AEOHA AEPYU AETLH AEXYK AFWTZ AFZKB AGAYW AGDGC AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHYZX AIIXL AJBLW AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP ARMRJ AZFZN B-. BA0 BGNMA CAG CCEZO CHBEP CIEJG COF CQIGP CS3 CSCUP CW9 D-I DPUIP EBS EJD ESBYG FA0 FEDTE FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GQ6 GQ7 HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IXD I~X I~Z J-C JBSCW JUIAU KOV M4Y MA- N2Q NDZJH NQJWS NU0 O9- O93 O9I O9J P9S PF0 QOR QOS R-E R89 R9I RIG ROL RPX RSV S.. S16 S1Z S27 S37 S3B SAP SCL SDH SHX SMD SNE SNX SOJ SPISZ SZ9 SZN T13 TCJ TSG TT1 TUC U2A U9L UG4 VC2 W48 W91 WK8 Z7U Z82 Z8V ZOVNA ~A9 ~WA -05 -0E -EM -SE -S~ 2JN 2JY 406 5VR 92M 9D9 9DE AACDK AAHNG AAIAL AAJBT AANZL AASML AATNV AAUYE AAXDM AAYZH ABAKF ABDZT ABECU ABHQN ABKZE ABMQK ABSXP ABTEG ABTKH ABWNU ABXPI ACAOD ACDTI ACHSB ACMDZ ACMLO ACOKC ACZOJ ADKNI ADRFC ADTPH AEFQL AEJRE AEMSY AESKC AEVLU AFBBN AFLOW AFQWF AFUIB AGJBK AGMZJ AGQEE AGRTI AHSBF AIAKS AIGIU AILAN AITGF AMXSW AMYLF AMYQR AOCGG AXYYD BDATZ CAJEE DDRTE DNIVK EBLON EIOEI FERAY FFXSO FIGPU FINBP FSGXE GNWQR GRRUI IKXTQ IWAJR JZLTJ LLZTM NPVJJ PT4 Q-- RHV RT5 SCLPG SDE SISQX SJYHP SNPRN SOHCF SRMVM SSLCW STPWE T8U TGQ U1F U1G U5E U5O UOJIU UTJUX UZXMN VFIZW YLTOR Z87 ZMTXR AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION ABQSL H13 NPM 7X8 4A8 93N ADHKG AGQPQ PSX |
ID | FETCH-LOGICAL-c407t-76da8741d6c268772fbf3f1e0ec2e49a7b162aee1fef031f78dd03d6ecc1bda3 |
ISSN | 1672-0733 2096-5230 1993-1352 |
IngestDate | Thu May 29 04:06:48 EDT 2025 Fri Jul 11 04:47:48 EDT 2025 Wed Feb 19 02:44:02 EST 2025 Thu Apr 24 23:08:56 EDT 2025 Tue Jul 01 04:14:36 EDT 2025 Fri Feb 21 02:37:18 EST 2025 Wed Feb 14 09:55:25 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | nephrotoxicity cisplatin Nrf2 Danshen oxidative stress |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c407t-76da8741d6c268772fbf3f1e0ec2e49a7b162aee1fef031f78dd03d6ecc1bda3 |
Notes | Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of Danshen on cisplatin-induced renal dysfunction was investigated in a mouse model. Danshen was administered to mice at a dose of 3 g/kg 4 days before and 3 days after cisplatin treatment. A single intraperitoneal injection of 20 mg/kg cisplatin was used to induce nephrotoxicity. The mice were sacrificed 72 h after cisplatin intoxication. Biochemical parameters including serum creatinine and blood urea nitrogen were analyzed. Histopathological changes of kidney tissues were detected using HE staining. Antioxidant enzymes(GSH-Px and SOD) and peroxidative product(MDA) were detected. Protein expressions of Nrf2 and its target genes including HO-1 and NQO1 were measured by Western blotting. The results showed that pretreatment with Danshen significantly reduced serum creatinine and blood urea nitrogen in the cisplatin-treated mice. Histopathological examination showed that Danshen mitigated the renal damage induced by cisplatin. Moreover, Danshen restored the activities of antioxidant enzymes(GSH-Px and SOD) and normalized the MDA contents in renal tissues. Western blotting revealed that Danshen enhanced the expressions of Nrf2 and its target genes in cisplatin-exposed mice. It was suggested that Danshen protects against the cisplatin-induced renal impairment in the mice, which is potentially associated with the upregulation of Nrf2-mediated signaling pathway. cisplatin; nephrotoxicity; Danshen; Nrf2; oxidative stress 42-1679/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 29058292 |
PQID | 1954423170 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | wanfang_journals_tjykdxxb_e201705019 proquest_miscellaneous_1954423170 pubmed_primary_29058292 crossref_citationtrail_10_1007_s11596_017_1801_1 crossref_primary_10_1007_s11596_017_1801_1 springer_journals_10_1007_s11596_017_1801_1 chongqing_primary_673963609 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-10-01 |
PublicationDateYYYYMMDD | 2017-10-01 |
PublicationDate_xml | – month: 10 year: 2017 text: 2017-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Wuhan |
PublicationPlace_xml | – name: Wuhan – name: China |
PublicationTitle | Current medical science |
PublicationTitleAbbrev | CURR MED SCI |
PublicationTitleAlternate | Journal of Zuazhong University of Science and Technology: Medical Edition |
PublicationTitle_FL | Journal of Huazhong University of Science and Technology(Medical Science) |
PublicationYear | 2017 |
Publisher | Huazhong University of Science and Technology Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China School of Pharmaceutical Sciences, Central South University, Changsha 410013, China%Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China%Department of Nephrology, the Second Xiangya Hospital Central South University, Changsha 410011, China%Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China |
Publisher_xml | – name: Huazhong University of Science and Technology – name: Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China – name: School of Pharmaceutical Sciences, Central South University, Changsha 410013, China%Department of Pharmacy, the Second Xiangya Hospital Central South University, Changsha 410011, China%Department of Nephrology, the Second Xiangya Hospital Central South University, Changsha 410011, China%Institute of Basic Theories of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China |
References | Yin, Yin, Yang (CR12) 2014; 151 Oh, Kim, Choi (CR24) 2014; 85 Chong, Zhou, Razmovski-Naumovski (CR28) 2013; 543 Zhang, Jiang, Ye (CR29) 2012; 13 Santos, Catao, Martins (CR7) 2007; 81 Noel, Hamad, Rabb (CR21) 2015; 88 Lu, Jin, Ma (CR13) 2015; 35 Kang, Oh, Sohn (CR16) 2004; 75 Xu, Shen, Bi (CR11) 2016; 38 Chirino, Pedraza-Chaverri (CR6) 2009; 61 Liu, Grigoryev, Crow (CR9) 2009; 76 Aleksunes, Goedken, Rockwell (CR10) 2010; 335 Zou, Lu, Mao (CR17) 2012; 18 Lee, Jeong, Yang (CR25) 2012; 139 Yu, Wang, Akinyi (CR27) 2015; 8 Hoek, Bloemendal, van der Velden (CR1) 2016; 8 Jin, Li, Zhao (CR18) 2015; 22 Darwish, Abo-Youssef, Khalaf (CR19) 2016; 31 Cornejo, Vargas, Videla (CR22) 2013; 39 Zhou, Qu, Li (CR26) 2014; 9 Guan, Ma, Zhang (CR14) 2013; 8 Latcha, Jaimes, Patil (CR2) 2016; 11 Miller, Tadagavadi, Ramesh (CR5) 2010; 2 Ries, Klastersky (CR3) 1986; 8 Shelton, Park, Copple (CR20) 2013; 84 Li, Zhang, Ma (CR15) 2014; 2014 Lv, Yao, Wang (CR8) 2016; 36 Arunkumar, Viswanatha, Radheshyam (CR4) 2012; 2 Shiraishi, Curtis, Truong (CR23) 2000; 278 PA Arunkumar (1801_CR4) 2012; 2 LM Shelton (1801_CR20) 2013; 84 SE Lee (1801_CR25) 2012; 139 J Yu (1801_CR27) 2015; 8 L Li (1801_CR15) 2014; 2014 J Hoek (1801_CR1) 2016; 8 M Liu (1801_CR9) 2009; 76 Q Lv (1801_CR8) 2016; 36 NA Santos (1801_CR7) 2007; 81 S Noel (1801_CR21) 2015; 88 LM Aleksunes (1801_CR10) 2010; 335 DG Kang (1801_CR16) 2004; 75 YI Chirino (1801_CR6) 2009; 61 GS Oh (1801_CR24) 2014; 85 F Shiraishi (1801_CR23) 2000; 278 L Xu (1801_CR11) 2016; 38 P Cornejo (1801_CR22) 2013; 39 MA Darwish (1801_CR19) 2016; 31 S Latcha (1801_CR2) 2016; 11 CM Chong (1801_CR28) 2013; 543 RP Miller (1801_CR5) 2010; 2 Y Zhang (1801_CR29) 2012; 13 F Ries (1801_CR3) 1986; 8 J Jin (1801_CR18) 2015; 22 J Zhou (1801_CR26) 2014; 9 C Zou (1801_CR17) 2012; 18 X Lu (1801_CR13) 2015; 35 S Guan (1801_CR14) 2013; 8 D Yin (1801_CR12) 2014; 151 22155388 - J Ethnopharmacol. 2012 Jan 31;139(2):541-8 17216432 - Arch Toxicol. 2007 Jul;81(7):495-504 15302225 - Life Sci. 2004 Aug 27;75(15):1801-16 23562886 - Neurosci Lett. 2013 May 24;543:121-5 23783243 - Kidney Int. 2013 Dec;84(6):1090-5 18986801 - Exp Toxicol Pathol. 2009 May;61(3):223-42 24025646 - Kidney Int. 2014 Mar;85(3):547-60 22515799 - J Altern Complement Med. 2012 Apr;18(4):394-401 27550472 - J Biochem Mol Toxicol. 2017 Jan;31(1):1-9 23554160 - Biofactors. 2013 Sep-Oct;39(5):514-21 26838739 - J Huazhong Univ Sci Technolog Med Sci. 2016 Feb;36(1):48-52 20605904 - J Pharmacol Exp Ther. 2010 Oct;335(1):2-12 26649656 - Kidney Int. 2015 Dec;88(6):1217-1218 27355131 - Int Immunopharmacol. 2016 Sep;38:385-94 3538860 - Am J Kidney Dis. 1986 Nov;8(5):368-79 19436334 - Kidney Int. 2009 Aug;76(3):277-85 25981918 - Phytomedicine. 2015 May 15;22(5):528-35 26891330 - Cancers (Basel). 2016 Feb 16;8(2):null 10807584 - Am J Physiol Renal Physiol. 2000 May;278(5):F726-36 22069563 - Toxins (Basel). 2010 Nov;2(11):2490-518 26237835 - J Tradit Chin Med. 2015 Jun;35(3):306-11 23202971 - Int J Mol Sci. 2012 Oct 22;13(10):13621-66 27073199 - Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1173-9 26628961 - Int J Clin Exp Med. 2015 Sep 15;8(9):14793-804 24066136 - PLoS One. 2013 Sep 16;8(9):e74318 24991814 - PLoS One. 2014 Jul 03;9(7):e101668 24269771 - J Ethnopharmacol. 2014;151(1):667-74 23569986 - Asian Pac J Trop Biomed. 2012 Aug;2(8):640-4 24696648 - ScientificWorldJournal. 2014 Feb 13;2014:572697 |
References_xml | – volume: 8 start-page: e74318 issue: 9 year: 2013 ident: CR14 article-title: Danshen (Salvia miltiorrhiza) injection suppresses kidney injury induced by iron overload in mice publication-title: PLoS One doi: 10.1371/journal.pone.0074318 – volume: 335 start-page: 2 issue: 1 year: 2010 end-page: 12 ident: CR10 article-title: Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.110.170084 – volume: 36 start-page: 48 issue: 1 year: 2016 end-page: 52 ident: CR8 article-title: Biliverdin protects against cisplatin-induced apoptosis of renal tubular epithelial cells publication-title: J Huazhong Univ Sci Technol Med Sci doi: 10.1007/s11596-016-1540-8 – volume: 18 start-page: 394 issue: 4 year: 2012 end-page: 401 ident: CR17 article-title: Chinese herbal medicine Danshen formulations for preventing renal disease in Henoch-Schonlein Purpura: a systematic review and meta-analysis publication-title: J Altern Complement Med doi: 10.1089/acm.2011.0041 – volume: 75 start-page: 1801 issue: 15 year: 2004 end-page: 1816 ident: CR16 article-title: Lithospermic acid B isolated from Salvia miltiorrhiza ameliorates ischemia/reperfusion-induced renal injury in rats publication-title: Life Sci doi: 10.1016/j.lfs.2004.02.034 – volume: 84 start-page: 1090 issue: 6 year: 2013 end-page: 1095 ident: CR20 article-title: Role of Nrf2 in protection against acute kidney injury publication-title: Kidney Int doi: 10.1038/ki.2013.248 – volume: 88 start-page: 1217 issue: 6 year: 2015 end-page: 1218 ident: CR21 article-title: Reviving the promise of transcription factor Nrf2-based therapeutics for kidney diseases publication-title: Kidney Int doi: 10.1038/ki.2015.328 – volume: 22 start-page: 528 issue: 5 year: 2015 end-page: 535 ident: CR18 article-title: Protective effect of Wuzhi tablet (Schisandra sphenanthera extract) against cisplatin-induced nephrotoxicity via Nrf2-mediated defense response publication-title: Phytomedicine doi: 10.1016/j.phymed.2015.03.003 – volume: 81 start-page: 495 issue: 7 year: 2007 end-page: 504 ident: CR7 article-title: Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria publication-title: Arch Toxicol doi: 10.1007/s00204-006-0173-2 – volume: 31 start-page: 1 issue: 1 year: 2016 end-page: 9 ident: CR19 article-title: Vitamin E mitigates cisplatin-induced nephrotoxicity due to reversal of oxidative/nitrosative stress, suppression of inflammation and reduction of total renal platinum accumulation publication-title: J Biochem Mol Toxic – volume: 39 start-page: 514 issue: 5 year: 2013 end-page: 521 ident: CR22 article-title: Nrf2-regulated phase-II detoxification enzymes and phase-III transporters are induced by thyroid hormone in rat liver publication-title: Biofactors doi: 10.1002/biof.1094 – volume: 35 start-page: 306 issue: 3 year: 2015 end-page: 311 ident: CR13 article-title: Danshen (Radix Salviae Miltiorrhizae) reverses renal injury induced by myocardial infarction publication-title: J Tradit Chin Med doi: 10.1016/S0254-6272(15)30102-3 – volume: 9 start-page: e101668 issue: 7 year: 2014 ident: CR26 article-title: Salvianolic acid B attenuates toxin-induced neuronal damage via Nrf2-dependent glial cells-mediated protective activity in Parkinson's disease models publication-title: PLoS One doi: 10.1371/journal.pone.0101668 – volume: 61 start-page: 223 issue: 3 year: 2009 end-page: 242 ident: CR6 article-title: Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity publication-title: Exp Toxicol Pathol doi: 10.1016/j.etp.2008.09.003 – volume: 8 start-page: 21 issue: 2 year: 2016 ident: CR1 article-title: Nephrotoxicity as a dose-limiting factor in a high-dose cisplatin-based chemoradiotherapy regimen for head and neck carcinomas publication-title: Cancers doi: 10.3390/cancers8020021 – volume: 139 start-page: 541 issue: 2 year: 2012 end-page: 548 ident: CR25 article-title: Extract of Salvia miltiorrhiza (Danshen) induces Nrf2-mediated heme oxygenase-1 expression as a cytoprotective action in RAW 264.7 macrophages publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2011.11.046 – volume: 13 start-page: 13621 issue: 10 year: 2012 end-page: 13666 ident: CR29 article-title: Tanshinones: sources, pharmacokinetics and anti-cancer activities publication-title: Int J Mol Sci doi: 10.3390/ijms131013621 – volume: 2 start-page: 640 issue: 8 year: 2012 end-page: 644 ident: CR4 article-title: Science behind cisplatin-induced nephrotoxicity in humans: a clinical study publication-title: Asian Pac J Trop Biomed doi: 10.1016/S2221-1691(12)60112-9 – volume: 543 start-page: 121 year: 2013 end-page: 125 ident: CR28 article-title: Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells and dopaminergic neurons in zebrafish publication-title: Neurosci Lett doi: 10.1016/j.neulet.2013.02.069 – volume: 85 start-page: 547 issue: 3 year: 2014 end-page: 560 ident: CR24 article-title: Pharmacological activation of NQO1 increases NAD+ levels and attenuates cisplatin-mediated acute kidney injury in mice publication-title: Kidney Int doi: 10.1038/ki.2013.330 – volume: 11 start-page: 1173 issue: 7 year: 2016 end-page: 1179 ident: CR2 article-title: Long-term renal outcomes after cisplatin treatment publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.08070715 – volume: 278 start-page: F726 issue: 5 year: 2000 end-page: F736 ident: CR23 article-title: Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.2000.278.5.F726 – volume: 8 start-page: 14793 issue: 9 year: 2015 end-page: 14804 ident: CR27 article-title: Danshensu protects isolated heart against ischemia reperfusion injury through activation of Akt/ERK1/2/Nrf2 signaling publication-title: Int J Clin Exp Med – volume: 2014 start-page: 572697 year: 2014 ident: CR15 article-title: Salvia miltiorrhiza injection ameliorates renal damage induced by lead exposure in mice publication-title: Scientific World Journal – volume: 2 start-page: 2490 issue: 11 year: 2010 end-page: 2518 ident: CR5 article-title: Mechanisms of cisplatin nephrotoxicity publication-title: Toxins doi: 10.3390/toxins2112490 – volume: 38 start-page: 385 year: 2016 end-page: 394 ident: CR11 article-title: Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2016.06.024 – volume: 151 start-page: 667 issue: 1 year: 2014 end-page: 674 ident: CR12 article-title: Renoprotection of Danshen Injection on streptozotocin-induced diabetic rats, associated with tubular function and structure publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2013.11.025 – volume: 8 start-page: 368 issue: 5 year: 1986 end-page: 379 ident: CR3 article-title: Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity publication-title: Am J Kidney Dis doi: 10.1016/S0272-6386(86)80112-3 – volume: 76 start-page: 277 issue: 3 year: 2009 end-page: 285 ident: CR9 article-title: Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice publication-title: Kidney Int doi: 10.1038/ki.2009.157 – volume: 139 start-page: 541 issue: 2 year: 2012 ident: 1801_CR25 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2011.11.046 – volume: 36 start-page: 48 issue: 1 year: 2016 ident: 1801_CR8 publication-title: J Huazhong Univ Sci Technol Med Sci doi: 10.1007/s11596-016-1540-8 – volume: 2 start-page: 640 issue: 8 year: 2012 ident: 1801_CR4 publication-title: Asian Pac J Trop Biomed doi: 10.1016/S2221-1691(12)60112-9 – volume: 76 start-page: 277 issue: 3 year: 2009 ident: 1801_CR9 publication-title: Kidney Int doi: 10.1038/ki.2009.157 – volume: 543 start-page: 121 year: 2013 ident: 1801_CR28 publication-title: Neurosci Lett doi: 10.1016/j.neulet.2013.02.069 – volume: 11 start-page: 1173 issue: 7 year: 2016 ident: 1801_CR2 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.08070715 – volume: 2 start-page: 2490 issue: 11 year: 2010 ident: 1801_CR5 publication-title: Toxins doi: 10.3390/toxins2112490 – volume: 61 start-page: 223 issue: 3 year: 2009 ident: 1801_CR6 publication-title: Exp Toxicol Pathol doi: 10.1016/j.etp.2008.09.003 – volume: 39 start-page: 514 issue: 5 year: 2013 ident: 1801_CR22 publication-title: Biofactors doi: 10.1002/biof.1094 – volume: 151 start-page: 667 issue: 1 year: 2014 ident: 1801_CR12 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2013.11.025 – volume: 38 start-page: 385 year: 2016 ident: 1801_CR11 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2016.06.024 – volume: 278 start-page: F726 issue: 5 year: 2000 ident: 1801_CR23 publication-title: Am J Physiol Renal Physiol doi: 10.1152/ajprenal.2000.278.5.F726 – volume: 31 start-page: 1 issue: 1 year: 2016 ident: 1801_CR19 publication-title: J Biochem Mol Toxic doi: 10.1002/jbt.21833 – volume: 81 start-page: 495 issue: 7 year: 2007 ident: 1801_CR7 publication-title: Arch Toxicol doi: 10.1007/s00204-006-0173-2 – volume: 75 start-page: 1801 issue: 15 year: 2004 ident: 1801_CR16 publication-title: Life Sci doi: 10.1016/j.lfs.2004.02.034 – volume: 85 start-page: 547 issue: 3 year: 2014 ident: 1801_CR24 publication-title: Kidney Int doi: 10.1038/ki.2013.330 – volume: 35 start-page: 306 issue: 3 year: 2015 ident: 1801_CR13 publication-title: J Tradit Chin Med doi: 10.1016/S0254-6272(15)30102-3 – volume: 8 start-page: 21 issue: 2 year: 2016 ident: 1801_CR1 publication-title: Cancers doi: 10.3390/cancers8020021 – volume: 2014 start-page: 572697 year: 2014 ident: 1801_CR15 publication-title: Scientific World Journal – volume: 335 start-page: 2 issue: 1 year: 2010 ident: 1801_CR10 publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.110.170084 – volume: 8 start-page: 14793 issue: 9 year: 2015 ident: 1801_CR27 publication-title: Int J Clin Exp Med – volume: 13 start-page: 13621 issue: 10 year: 2012 ident: 1801_CR29 publication-title: Int J Mol Sci doi: 10.3390/ijms131013621 – volume: 22 start-page: 528 issue: 5 year: 2015 ident: 1801_CR18 publication-title: Phytomedicine doi: 10.1016/j.phymed.2015.03.003 – volume: 8 start-page: e74318 issue: 9 year: 2013 ident: 1801_CR14 publication-title: PLoS One doi: 10.1371/journal.pone.0074318 – volume: 84 start-page: 1090 issue: 6 year: 2013 ident: 1801_CR20 publication-title: Kidney Int doi: 10.1038/ki.2013.248 – volume: 9 start-page: e101668 issue: 7 year: 2014 ident: 1801_CR26 publication-title: PLoS One doi: 10.1371/journal.pone.0101668 – volume: 18 start-page: 394 issue: 4 year: 2012 ident: 1801_CR17 publication-title: J Altern Complement Med doi: 10.1089/acm.2011.0041 – volume: 88 start-page: 1217 issue: 6 year: 2015 ident: 1801_CR21 publication-title: Kidney Int doi: 10.1038/ki.2015.328 – volume: 8 start-page: 368 issue: 5 year: 1986 ident: 1801_CR3 publication-title: Am J Kidney Dis doi: 10.1016/S0272-6386(86)80112-3 – reference: 27073199 - Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1173-9 – reference: 19436334 - Kidney Int. 2009 Aug;76(3):277-85 – reference: 22515799 - J Altern Complement Med. 2012 Apr;18(4):394-401 – reference: 23562886 - Neurosci Lett. 2013 May 24;543:121-5 – reference: 17216432 - Arch Toxicol. 2007 Jul;81(7):495-504 – reference: 20605904 - J Pharmacol Exp Ther. 2010 Oct;335(1):2-12 – reference: 22155388 - J Ethnopharmacol. 2012 Jan 31;139(2):541-8 – reference: 26628961 - Int J Clin Exp Med. 2015 Sep 15;8(9):14793-804 – reference: 24696648 - ScientificWorldJournal. 2014 Feb 13;2014:572697 – reference: 15302225 - Life Sci. 2004 Aug 27;75(15):1801-16 – reference: 26237835 - J Tradit Chin Med. 2015 Jun;35(3):306-11 – reference: 27355131 - Int Immunopharmacol. 2016 Sep;38:385-94 – reference: 24025646 - Kidney Int. 2014 Mar;85(3):547-60 – reference: 18986801 - Exp Toxicol Pathol. 2009 May;61(3):223-42 – reference: 23554160 - Biofactors. 2013 Sep-Oct;39(5):514-21 – reference: 24269771 - J Ethnopharmacol. 2014;151(1):667-74 – reference: 27550472 - J Biochem Mol Toxicol. 2017 Jan;31(1):1-9 – reference: 23783243 - Kidney Int. 2013 Dec;84(6):1090-5 – reference: 23569986 - Asian Pac J Trop Biomed. 2012 Aug;2(8):640-4 – reference: 24991814 - PLoS One. 2014 Jul 03;9(7):e101668 – reference: 26891330 - Cancers (Basel). 2016 Feb 16;8(2):null – reference: 3538860 - Am J Kidney Dis. 1986 Nov;8(5):368-79 – reference: 24066136 - PLoS One. 2013 Sep 16;8(9):e74318 – reference: 25981918 - Phytomedicine. 2015 May 15;22(5):528-35 – reference: 22069563 - Toxins (Basel). 2010 Nov;2(11):2490-518 – reference: 26838739 - J Huazhong Univ Sci Technolog Med Sci. 2016 Feb;36(1):48-52 – reference: 26649656 - Kidney Int. 2015 Dec;88(6):1217-1218 – reference: 23202971 - Int J Mol Sci. 2012 Oct 22;13(10):13621-66 – reference: 10807584 - Am J Physiol Renal Physiol. 2000 May;278(5):F726-36 |
SSID | ssj0057624 ssib031263182 ssj0002039635 ssib051367596 ssib034325102 |
Score | 2.186353 |
Snippet | Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect of... Summary Danshen, an efficacious agent for cardiovascular diseases, has been found to play an essential role in kidney injury. In the present study, the effect... Danshen,an efficacious agent for cardiovascular diseases,has been found to play an essential role in kidney injury.In the present study,the effect of Danshen... |
SourceID | wanfang proquest pubmed crossref springer chongqing |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 761 |
SubjectTerms | Medicine Medicine & Public Health |
Title | Danshen Modulates Nrf2-mediated Signaling Pathway in Cisplatin-induced Renal Injury |
URI | http://lib.cqvip.com/qk/85740A/201705/673963609.html https://link.springer.com/article/10.1007/s11596-017-1801-1 https://www.ncbi.nlm.nih.gov/pubmed/29058292 https://www.proquest.com/docview/1954423170 https://d.wanfangdata.com.cn/periodical/tjykdxxb-e201705019 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFeEHfKYArSnkBGjnN_7CamCml7WSeVp8hJbNYC6Wgbse2H8Hs5x3acdIOJ8RK1keO6Pl_OxedGyJ4EGSZVxqjvJzEFCZHSgrOUpqFSqWQiUroXwdFxPD4NP02j6WDwqxe11KyLD-XVH_NK_oeqcA_oilmyd6CsmxRuwGegL1yBwnD9JxoDyVZnssZ2NtiFSwLPWipOdTYIapIYnCFMvjkoej-FzvErZ6tzDICrKZjjDbr_l7LWpTfmzWZ-dFu76bt15lhp2bkt9DHryYyuZo55CBuMLxYOMItGe0BgofSyw-KBTQv53MpOe_QA4qwNYjNgGTfi6gw7Im3GkLRMCQ_-r_kHNF_jYDWh_WvcMdLcg-8UTL9pnzGbajAWgFGPyyamfrsV2IlpNnFDFjCbGw0KGx6awOpBGlO_E3wuHLEr3Yxjcxib49gcrOptDuYH8M_t0eH-_nHLqQKfx8AMnWKI2blRrxBbhIXwIlvIcG7cvcDpMJ7W_fvWxa7zOK-tEQt94M7-ABJsKkw3rKCeB1_nndVK1F96KtLkEXlobRtvZID6mAxk_YTcP7LRG0_JicWr5_DqbeDVc3j1LF69We3dwKun8eoZvD4jk8OPk4MxtU09aBmyZE2TuBIpqLFVXPI4hc1VhQqUL5ksuQwzkRR-zIWUvpIK9lklaVWxoIqB1fhFJYLnZKte1PIl8STY_mUSwwNZFJahSFlZJjBTIALBQS0fkh23ifm5qd2CYYwZlsjLhoS125qXthw-dmX5lv8VDUPyzj3SznfL4LctrXLg2OiGE7VcNKsclwtGjJ-wIXlhiOim4xmLUp7xIXnfUjW3DGd122_tWcJ3g9fzy6_VxUWRS65LZoEp9-pOk-6QB907_5psrZeNfAMK-LrYtW_DLrl3yke_AaQE0bs |
linkProvider | Library Specific Holdings |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Danshen+modulates+Nrf2-mediated+signaling+pathway+in+cisplatin-induced+renal+injury&rft.jtitle=Current+medical+science&rft.au=Cao%2C+Si-si&rft.au=Yan%2C+Miao&rft.au=Hou%2C+Zhen-yan&rft.au=Chen%2C+Ying&rft.date=2017-10-01&rft.pub=Huazhong+University+of+Science+and+Technology&rft.issn=2096-5230&rft.eissn=2523-899X&rft.volume=37&rft.issue=5&rft.spage=761&rft.epage=765&rft_id=info:doi/10.1007%2Fs11596-017-1801-1&rft.externalDocID=10_1007_s11596_017_1801_1 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg |